Research Co. Makes Peace With FDA Over Suspect Drug Tests

Law360, Wilmington (April 24, 2012, 8:54 PM EDT) -- Bankrupt Cetero Research has reached a final resolution with the U.S. Food and Drug Administration over data irregularities at one of the pharmaceutical testing provider's labs, the company said Tuesday.

The FDA probe, which Cetero cited as a major factor in its financial woes, will require complete reanalysis of studies performed on various drugs at the company’s Houston bioanalytical laboratory between April 2005 and February 2008, Cetero said in a statement.

More recent studies scrutinized by the FDA will only need to be verified through an...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Contract Research Solutions, Inc.


Case Number

1:12-bk-11004

Court

Delaware

Nature of Suit

Date Filed

March 26, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.